We are live on ! Find out more
MHR

Matthew Hamilton Rosenberg Portfolio holdings

AUM $537M
1-Year Est. Return 18.21%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+18.21%
3 Year Est. Return
+48.25%
5 Year Est. Return
+48.63%
10 Year Est. Return
AUM
$537M
AUM Growth
+$48.7M
Cap. Flow
+$11.4M
Cap. Flow %
2.12%
Top 10 Hldgs %
57.54%
Holding
818
New
19
Increased
183
Reduced
114
Closed
26

No holdings matched the selected filter criteria.

Similar funds

Matthew Hamilton Rosenberg's Q2 2026 Portfolio in Review

As of Q2 2026, Matthew Hamilton Rosenberg held 818 positions worth $537M, up 10% from $488M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Matthew Hamilton Rosenberg's Q2 2026 filing shows 19 new, 183 increased, 114 reduced and 26 closed positions. Its largest new stake was AstraZeneca: 2,051 shares worth $389K. The largest sale was Vanguard Intermediate-Term Bond ETF, an estimated $2.52M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, up from 4.1% a quarter earlier, followed by Financials and Energy.

  • Matthew Hamilton Rosenberg's largest Q2 2026 buy was AstraZeneca: 2,051 shares worth $389K.
  • Matthew Hamilton Rosenberg added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2026, an estimated $4.06M increase.
  • Matthew Hamilton Rosenberg's biggest Q2 2026 reduction was Vanguard Intermediate-Term Bond ETF, cutting an estimated $2.52M.
  • Matthew Hamilton Rosenberg fully exited Vanguard Short Duration Tax-Exempt Bond ETF in Q2 2026, selling an estimated $244K.
  • Matthew Hamilton Rosenberg's ten largest holdings make up 58% of its $537M portfolio in Q2 2026.
  • Matthew Hamilton Rosenberg opened 19 new positions and closed 26 in Q2 2026.
  • Matthew Hamilton Rosenberg's portfolio value rose 10% quarter-over-quarter to $537M.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.